Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 59,881 shares at $75.15 ($4.6M) on 2024-02-23, disclosed to the SEC on 2024-02-27.
Scheduled sale ($4.6M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.15 | 2,356 | $177K | 3.8% |
| 2 | $75.15 | 2,356 | $177K | 3.8% |
| 3 | $75.96 | 6,980 | $530K | 11.4% |
| 4 | $75.96 | 6,980 | $530K | 11.4% |
| 5 | $76.95 | 5,545 | $427K | 9.2% |
| 6 | $76.95 | 5,545 |
| $427K |
| 9.2% |
| 7 | $77.56 | 119 | $9K | 0.2% |
| 8 | $79.03 | 30,000 | $2.4M | 51.0% |
| Total | $77.62 avg | 59,881 | $4.6M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |